Rarecells
Rarecells Inc. is a healthcare company focused on the development and commercialization of non-invasive Early Cancer Detection tests.
Based based in European Union (EU), Europe, Middle East, and Africa (EMEA), Rarecells works in biotechnology, health care, founded in 2010.
Within the biotechnology, health care space, the company focuses on its core offering rather than a broad product line.
Its base of operations is European Union (EU), Europe, Middle East, and Africa (EMEA).
It is recorded at the Series_A stage.
The company reports a headcount in the c_00011_00050 range.
Public records show total funding of about $13M.
| Sector | Biotechnology, Health Care |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2010 |
| Employees | c_00011_00050 |
| Stage | series_a |
| Total funding | $13,000,000 |
Website: www.rarecells.com
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account